Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet, Paclitaxel, and Herceptin in HER2+ Breast Cancer
NCT02015676Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2001
- Primary completion
- Sep 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in breast cancer, sponsored by Roche. Started Jul 2001; status: completed.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02015676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015676.